99 related articles for article (PubMed ID: 2116668)
21. Ifosfamide in the treatment of non-small cell lung cancer.
Ettinger DS
Semin Oncol; 1989 Feb; 16(1 Suppl 3):31-8. PubMed ID: 2539646
[TBL] [Abstract][Full Text] [Related]
22. Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.
Chang AY; Asbury RF; Boros L; Garrow GC; Hsieh S
Semin Oncol; 1995 Jun; 22(3 Suppl 7):9-12. PubMed ID: 7610399
[TBL] [Abstract][Full Text] [Related]
23. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
24. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.
Dechant KL; Brogden RN; Pilkington T; Faulds D
Drugs; 1991 Sep; 42(3):428-67. PubMed ID: 1720382
[TBL] [Abstract][Full Text] [Related]
25. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer.
Focan C; Boossy J; Focan-Henrard D; Reginster M; Claessens JJ
Cancer Chemother Pharmacol; 1989; 23(3):192-3. PubMed ID: 2493996
[TBL] [Abstract][Full Text] [Related]
27. Nursing implications in the administration of ifosfamide and mesna.
Richters JE
Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
[No Abstract] [Full Text] [Related]
28. Cyclophosphamide and ifosfamide: role of uroprotective agents.
Williams SD; Munshi N; Einhorn LH; Loehrer PJ
Cancer Invest; 1990; 8(2):269. PubMed ID: 2119246
[No Abstract] [Full Text] [Related]
29. Severe renal failure following high-dose ifosfamide and mesna.
Willemse PH; de Jong PE; Elema JD; Mulder NH
Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer.
Gurney H; de Campos ES; Dodwell D; Kamthan A; Thatcher N
Eur J Cancer; 1991; 27(5):565-8. PubMed ID: 1647182
[TBL] [Abstract][Full Text] [Related]
31. Ifosfamide/mesna encephalopathy.
McCallum AK
Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
[No Abstract] [Full Text] [Related]
32. Continuously improving ifosfamide/mesna: a winning combination.
Anderson P
Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648
[No Abstract] [Full Text] [Related]
33. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
Steger GG; Dittrich C; Schlappack O; Mader R; Herold C; Brade WP; Keller A; Moser K
J Cancer Res Clin Oncol; 1988; 114(6):602-4. PubMed ID: 3144554
[TBL] [Abstract][Full Text] [Related]
34. Ifosfamide/mesa and encephalopathy.
Cantwell BM; Harris AL
Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
[No Abstract] [Full Text] [Related]
35. Ifosfamide with mesna uroprotection in the management of lung cancer.
Holoye PY; Glisson BS; Lee JS; Dhingra HM; Murphy WK; Umsawasdi T; Levy JK; Jeffries D; Raber MN; Hong WK
Am J Clin Oncol; 1990 Apr; 13(2):148-55. PubMed ID: 2156418
[TBL] [Abstract][Full Text] [Related]
36. Prediction of ifosfamide/mesna associated encephalopathy.
Meanwell CA; Blake AE; Kelly KA; Honigsberger L; Blackledge G
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):815-9. PubMed ID: 3095121
[TBL] [Abstract][Full Text] [Related]
37. Infusion of ifosfamide plus mesna.
Rowland CG; Bradford E; Adams P; Haines-Nutt RP; Jakobson K
Lancet; 1984 Aug; 2(8400):468. PubMed ID: 6147537
[No Abstract] [Full Text] [Related]
38. Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.
Klein HO; Wickramanayake PD; Christian E; Coerper C; Graf L
Cancer Treat Rev; 1983 Sep; 10 Suppl A():83-92. PubMed ID: 6414699
[No Abstract] [Full Text] [Related]
39. High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.
Klein HO; Wickramanayake PD; Coerper C; Christian E; Pohl J; Brock N
Cancer Treat Rev; 1983 Sep; 10 Suppl A():167-73. PubMed ID: 6414691
[No Abstract] [Full Text] [Related]
40. Ifosfamide/mesna nomogram and serum albumin.
Hill PG; Harrop JS
Lancet; 1986 Oct; 2(8513):986. PubMed ID: 2877171
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
